NVIDIA's Drug Discovery AI Platform Secures Eli Lilly, Thermo Fisher Partnerships Across Three Continents
NVIDIA's BioNeMo platform has partnered with Eli Lilly and Thermo Fisher Scientific to deploy AI-driven drug discovery infrastructure spanning pharmaceutical labs in North America and Europe. The collaborations connect laboratory automation with machine learning models, enabling iterative experiments where AI predictions guide physical testing. Multiple biotech companies including Natera, Basecamp Research, and Owkin have launched production tools on the platform in early 2026.
Salvado•